BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34775998)

  • 1. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
    Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
    J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment plan quality during online adaptive re-planning.
    van Timmeren JE; Chamberlain M; Krayenbuehl J; Wilke L; Ehrbar S; Bogowicz M; Hartley C; Zamburlini M; Andratschke N; Garcia Schüler H; Pavic M; Balermpas P; Ryu C; Guckenberger M; Tanadini-Lang S
    Radiat Oncol; 2020 Aug; 15(1):203. PubMed ID: 32825848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
    Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
    Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
    Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
    Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overview of adaptive radiotherapy in 2019: From implementation to clinical use].
    Badey A; Barateau A; Delaby N; Fau P; Garcia R; De Crevoisier R; Lisbona A
    Cancer Radiother; 2019 Oct; 23(6-7):581-591. PubMed ID: 31473088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer.
    de Jong R; Visser J; van Wieringen N; Wiersma J; Geijsen D; Bel A
    Radiat Oncol; 2021 Jul; 16(1):136. PubMed ID: 34301300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
    Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A daily end-to-end quality assurance workflow for MR-guided online adaptive radiation therapy on MR-Linac.
    Chen X; Ahunbay E; Paulson ES; Chen G; Li XA
    J Appl Clin Med Phys; 2020 Jan; 21(1):205-212. PubMed ID: 31799753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical physics challenges in clinical MR-guided radiotherapy.
    Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
    Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
    La Rosa A; Mittauer KE; Chuong MD; Hall MD; Kutuk T; Bassiri N; McCulloch J; Alvarez D; Herrera R; Gutierrez AN; Tolakanahalli R; Mehta MP; Kotecha R
    Med Dosim; 2023 Winter; 48(4):238-244. PubMed ID: 37330328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy.
    Nachbar M; Lo Russo M; Gani C; Boeke S; Wegener D; Paulsen F; Zips D; Roque T; Paragios N; Thorwarth D
    Z Med Phys; 2024 May; 34(2):197-207. PubMed ID: 37263911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.